Takuya Kobayakawa
7PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 24, 2025
Hybrid Molecules of Small Molecular and Peptidic HIV Fusion Inhibitors.Kohei Tsuji, Takuya Kobayakawa, Peter Bolah
|Feb 13, 2025
Diastereoselective synthesis of (Z)-fluoroalkene dipeptide isosteres utilizing chiral auxiliaries.Takuya Kobayakawa, Marisa Arioka, Kenichi Yamamoto
|Jan 20, 2025
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi
|Oct 20, 2023
Development of anti-HBV agents targeting HBV capsid proteins.Takuya Kobayakawa, Masayuki Amano, Miyuki Nakayama
|Mar 23, 2023
Dimerized fusion inhibitor peptides targeting the HR1-HR2 interaction of SARS-CoV-2.Kohei Tsuji, Kofi Baffour-Awuah Owusu, Yutaro Miura
|Feb 25, 2023
Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi
Pageof 2
Frequent Collaborators
7 joint publications
Kohei Tsuji
7 joint publications
Hirokazu Tamamura
3 joint publications
Takahiro Ishii
2 joint publications
Nobuyo Higashi-Kuwata
2 joint publications
Hironori Hayashi
2 joint publications
Haydar Bulut
2 joint publications
Hiromi Ogata-Aoki
2 joint publications
Nobutoki Takamune
2 joint publications
Naoki Kishimoto
2 joint publications
Shin-Ichiro Hattori
